SLCO1B3 and liver disorder: Thus, it is necessary to find endogenous biomarkers to evaluate the function of the OATP1B3 and P-gp vectorial transport (OATP1B3-P-gp) to predict changes in the pharmacokinetics of drugs transported through OATP1B3-P-gp in liver disease states.